Table 1.
Publication | Immunization | Challenge | Survival** | P value | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1st Author, Year | Antigen Type | Region* | Adjuvant | Immunization Route | Model | Route | Dose | ED50 | Control | Test | Fisher's Exact | Log-Rank |
Koizumi et al., 2004 (14) | His6 RPS-Ec | LigA d1'-d13 (68-1224) | Freund's | SQ | Mouse C3H/HeJ | ip | 106 | <103 | 2/5 | 9/10 | NS | 0.025 |
LigB d1'-d12 (68-1191) | 9/10 | NS | 0.036 | |||||||||
Palaniappan et al., 2006 (12) | GST RPS-Ec | LigA d0'-d7' (32-630) + LigA d7'-d13 (631-1225) | Al(OH)3 | SQ | Hamster | ip | 108 | 108 | 7/8 | 8/8 | NS | NA |
4/5 | 5/5 | NS | NA | |||||||||
4/7 | 8/8 | NS | NA | |||||||||
Silva et al., 2007 (104) | His6 RPF-Ec | LigA d7'-d13 (625-1224) | Freund's | SQ | Hamster | ip | 103 | 45 | 0/10 | 8/10 | <0.001 | <0.0001 |
LigB d2-d7' (131-645) | 0/10 | NS | NS | |||||||||
LigB d7'-d12 (625-1259) | 1/10 | NS | NS | |||||||||
Faisal et al., 2008 (105) | DNA | LigA d0'-d7' (32-630) + LigA d7'-d13 (631-1225) | none | IM | Hamster | ip | 108 | 108 | 4/8 | 8/8 | NS | NA |
5/8 | 8/8 | NS | NA | |||||||||
6/8 | 8/8 | NS | NA | |||||||||
Faisal et al., 2009 (106) | RPS-Ec | LigA d7'-d13 (631-1225) | Al(OH)3 | Hamster | ip | 108 | 108 | 0/8 | 4/8 | NS | <0.01 | |
liposome | SQ | 0/8 | 7/8 | <0.01 | <0.001 | |||||||
PLGA | 0/8 | 6/8 | <0.01 | 0.001 | ||||||||
Yan et al., 2009 (107) | RPS-Ec + His6 RPS-Ec + RPS-Ec | LigB d0'-d7' (32-630) + LigB d7'-d12 (631-1418) + LigB CTE (1419-1890) | Al(OH)3 | SQ | Hamster | ip | 2×108 | 108 | 1/8 | 7/8 | 0.01 | 0.001 |
RPS-Ec | LigB d0'-d7' (32-630) | 6/8 | <0.05 | <0.01 | ||||||||
His6 RPS-Ec | Lig B d7'-d12 (631-1418) | 4/8 | NS | NS | ||||||||
RPS-Ec | LigB CTE (1419-1890) | 3/8 | NS | NS | ||||||||
Cao et al., 2011 (108) | RPS-Ec | LigB d0'-d7' (32-630) | Emulsigen | SQ | Hamster | ip | 250 | 100 | 0/6 | 2/6 | NS | <0.05 |
LigB d4 / LigB d12 | 3/6 | NS | <0.02 | |||||||||
LigB d4-d7' / LigB d12 | 3/6 | NS | <0.05 | |||||||||
Coutinho et al., 2011 (109) | His6 RPS-Ec | LigA d7'-d13 (631-1224) | Freund's | SQ | Hamster | ip | 1000 | 50 | 0/4 | 4/4 | <0.05 | 0.01 |
LigA d7'-d11 (631-1033) | 2/4 | NS | 0.01 | |||||||||
LigA d7'-d9 (631-851) | 0/4 | NS | NS | |||||||||
LigA d10-d13 (852-1224) | 4/4 | <0.05 | 0.008 | |||||||||
LigA d10-d12 (852-1124) | 4/4 | <0.05 | 0.008 | |||||||||
LigA d11-d13 (943-1224) | 4/4 | <0.05 | 0.008 | |||||||||
LigA d11-d12 (943-1124) | 1/4 | NS | NS | |||||||||
LigA d12-d13 (1034-1224) | 2/4 | NS | 0.01 | |||||||||
Lucas et al., 2011 (110) | His6-RPI-Ec | LigA d7'-d13 (625-1224) | Al(OH)3 | NA | Hamster | ip | 2000 | 10 | 2/10 | 0/10 | NS | NA |
Forster et al., 2013 (111) | DNA | LigA d7'-d13 (629-1224) | Al(OH)3 | IM | Hamster | iph | 10 | 2 | 0/6 | 0/8 | NS | NS |
LigB: d7'-d12 (629-1112) | 0/8 | NS | NS | |||||||||
LigB d0-d7' (1-628) | 5/8 | <0.05 | <0.01 | |||||||||
LigB CTE (1113-1501) | 0/8 | NS | NS | |||||||||
LigB CTE (1502-1891) | 0/8 | NS | NS | |||||||||
Lourdault et al., 2014 (112) | Lipoprotein | OspA SP / LigA d7'-d13 (631-1224) | E. coli | oral | Hamster | ip | 1000 | 20 | 0/8 | 3/8 | NS | <0.0001 |
id | 100 | <10 | 0/8 | 5/8 | <0.05 | <0.02 | ||||||
Hartwig et al., 2014 (113) | His6 mRP-Pp | LigA d7'-d13 (625-1224) | Al(OH)3 | IM | Hamster | ip | 1300 | 36 | 0/6 | 6/6 | <0.01 | <0.01 |
His6 dmRP-Pp | LigA d7'-d13 (625-1224) | 0/6 | NS | NS | ||||||||
Bacelo et al., 2014 (114) | His6 RPF-Ec | LigA d7'-d13 (625-1224) | Al(OH)3 | SQ | Hamster | ip | 1300 | 36 | 0/6 | 4/6 | NS | <0.001 |
CpG | 0/6 | 0/6 | NS | NS | ||||||||
xanthan | 1/5 | 6/6 | <0.05 | <0.01 | ||||||||
CpG + xanthan | 6/6 | <0.05 | <0.01 | |||||||||
Forster et al., 2015 (115) | RPF-Ec p,b | LigB d0-d7' (1-628) | Al(OH)3 | IM | Hamster | iph | 10 | 2 | 0/5 | 0/6 | NS | <0.05 |
DNAp/RPF-Ecb | 5/6 | <0.02 | <0.01 | |||||||||
DNAp/DNAb | 2/5 | NS | <0.01 | |||||||||
DNAp/DNAb | none | 0/5 | NS | NS | ||||||||
Oliviera et al., 2016 (116) | His6 RPF-Ec | LigA d7'-d13 (625-1224) | Al(OH)3 | SQ | Hamster | ip | 1300 | 260 | 0/6 | 4/6 | NS | <0.001 |
CpG | 0/6 | 1/6 | NS | <0.01 | ||||||||
CpG + MWCNT | 0/6 | 1/6 | NS | <0.01 | ||||||||
MWCNT | 0/6 | 0/6 | NS | <0.01 | ||||||||
Conrad et al., 2017 (117) | His6 RPF-Ec | LigB d2-d7' (131-645) | Al(OH)3 | IM | Hamster | ip | 200 | 18 | 0/10 | 10/10 | <0.0001 | <0.0001 |
Evangelista et al., 2017 (118) | His6 RPS-Ec | LigA d7'-d13 (631-1224) | Freund's | SQ | Hamster | ip | 105 | 20 | 0/5 | 8/8 | <0.001 | 0.0001 |
LigB d0-d7 (19-672) | 3/8 | NS | NS | |||||||||
LigA d7'-d11 (631-1224) + LigB d0-d7 (19-672) | 8/8 | <0.001 | 0.0001 | |||||||||
Hsieh et al., 2017 (31) | (NA) RPS-Ec | LigB d7 (579-674) | Al(OH)3 | SQ | Hamster | ip | 250 | NA | 1/6 | 0/6 | NS | NS |
LigB d10 (848-943) | 0/6 | NS | NS | |||||||||
LigB d10'(848-889) / d7'(621-674) | 6/6 | <0.02 | <0.01 | |||||||||
da Cunha et al., 2019 (119) | His6 RPF-Ec p,b | LigA d11-d13 (943-1224) / LigB d2-d7' (131-648) | Al(OH)3 | IM | Hamster | ip | 200 | 40 | 0/8 | 8/8 | <0.001 | <0.001 |
His6 RPF-Ec p,b | Montanide | 8/8 | <0.001 | <0.001 | ||||||||
DNAp/DNAb | none/none | 2/8 | NS | NS | ||||||||
DNAp/H6-RPFb | none/ Al(OH)3 |
8/8 | <0.001 | <0.001 | ||||||||
Techawiwattanaboon et al., 2019 (120) | His6 RPF-Ec | LigA d7'-13 (631-1224) | liposome + MPL + QS21 | SQ | Hamster | ip | 200 | 20 | 0/5 | 3/5 | NS | <0.05 |
LigA d7'-d13 (631-1224) + LenA + LcpA + Lsa23 | 3/5 | NS | <0.01 | |||||||||
Techawiwattanaboon et al., 2020 (121) | His6 RPF-Ec | LigA d7'-13 (631-1224) | liposome + MPL + QS21 | IM | Hamster | ip | 200 | 20 | 0/5 | 3/5 | NS | <0.05 |
SQ | 3/5 | NS | <0.05 |
Al(OH)3, aluminum hydroxide; GST, glutathione-S-transferase; RPS-Ec, recombinant protein produced in E. coli and purified as soluble protein; RPF-Ec, recombinant protein produced in E. coli, solubilized in urea, and folded; RPI-Ec, recombinant protein produced in E. coli and solubilized in urea; d, Ig-like domain; CTE, C-terminal extension; p, prime; b, boost; iph, intraperitoneal inoculation with a heterologous strain; SP, signal peptide; IM, intramuscular; SQ, subcutaneous; PLGA, poly-lactic-co-glycolic acid; mRP-Pp, mannosylated recombinant purified protein produced in Pichia pastoris; dmRP-Pp, demannosylated recombinant purified protein produced in Pichia pastoris, NS, not significant.
*Chimeric constructs are shown with sequences separated by a slash (/). LigA and LigB domains included in constructs are numbered. An apostrophe (‘) is used to indicate that the endpoint of the sequence lies within a domain. Amino acid coordinates are shown in parentheses.
** All experimental trials in a study may not be shown. In those cases, a representative trial is shown.